(2S)-2-AMINO-2-(3,4-DIFLUOROPHENYL)ACETIC ACID, 95.0%, 500mg

3-Dimethylamino-1-phenyl-propenone, 95.0%, 5g

3-Bromo-4-nitrophenol, 95.0%, 10g

3-Cyano-1H-pyrazole-5-carboxylic acid, 95.0%, 250mg

[[(3,5-Dimethyl-1H-pyrrol-2-yl)(3,5-dimethyl-2H-pyrrol-2-ylidene)methyl]methane](difluoroborane)>98.0%(GC)1g

6-Bromoimidazo[1,2-a]pyridine-3-carboxamide, 97.0%, 1g

2-Amino-5-nitropyridine, 99.00%, 25g

1-Methyl-4-(trifluoromethyl)-1H-pyrrole-3-carboxylic acid, 95.0%, 5g

2-(2-Methoxyethoxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 1g

(S)-4-ISOPROPYL-2-(ISOQUINOLIN-1-YL)-4,5-DIHYDROOXAZOLE, 95%, 1g

GC capillary column ROTI®Cap-1, 60 m, 0.32 mm, 1.00 µm, 1 Piece(s)

4-(aminomethyl)-N,N-dimethylbenzamide hydrochloride, 95.0%, 10g

4,4''-Dinitro-5'-(4-nitrophenyl)-1,1':3',1''-terphenyl, 97%, 5g